Drug Recall Terminated Historical recordClass II
TMG 100 MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
FDA Drug Recalls
Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.
Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.
Filters
Drug Recall Terminated Historical recordClass II
THIAMINE 100 MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
THIAMINE 100 MG/ML, 2ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TESTOSTERONE CYP 50 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, d) 4ML Vials, and e) 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TESTOSTERONE CYP 25 MG/ML W/PRES (BENZYL ETOH 2%), 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TESTOSTERONE CYP 20 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials and b) 3ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TESTOSTERONE CYP 200 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, d) 4ML, and e) 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TESTOSTERONE CYP 100 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, and d) 5 ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TAURINE 50 MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
TAURINE 50 MG/ML (PF), In a) 1ML Vials, b) 10ML Vials, and c) 20ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
SELENIUM 200MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
RIBOFLAVIN 10MG/ML (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass III
PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
PYRIDOXINE HCL 100MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
PYRIDOXAL 50 MG/THIAMINE 50 MG/LIDOCAINE 1% NS (PF), 2ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
PROLINE 100MG/ML (PF), 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
PROCAINE 2% (PF), In a) 2ML Vials and b) 10ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
NIACINAMIDE 100 MG/ML (PF), In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
NANDROLONE DEC 200MG/ML W/PRES. (BENZYL ETOH 10%), In a) 2ML Vials, b) 4ML Vials, and c) 5ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Drug Recall Terminated Historical recordClass II
NA ASCORBATE 500MG/ML NON-CORN (PF), In a) 10ML Vials, b) 50ML Vials, and c) 100ML Vials, MEDAUS PHARMACY
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- May 13, 2016
- Reported by FDA
- July 20, 2016
- Distribution
- U.S. Nationwide, Japan, and New Zealand.
Data last updated:
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.
